BOULDER, CO – Auddia Inc. (NASDAQ: AUUD) on Tuesday spotlighted Influence Healthcare, a healthtech company leveraging artificial intelligence and vertical integration to enable surgeons to lead value-based care (VBC) adoption in surgical specialties. The announcement comes as Auddia prepares to file its S-4 registration statement with the Securities and Exchange Commission, a critical step in its proposed merger with Thramann Holdings, LLC.
Influence Healthcare is designed as an alternative to both hospital employment and private-equity rollups, which often reduce physician autonomy or prioritize financial engineering over clinical leadership. The platform organizes surgeons into vertically integrated Value Based Enterprises (VBEs) that contract for bundled case-rate payments in high-spend specialties such as spine and total joint surgery. These VBEs are supported by AI workflows that automate documentation, coding, episode validation, care coordination, staffing, supply chain, and logistics, allowing surgeons to focus on patient care.
“Healthcare is about a physician and patient entering into a relationship to optimize delivery of the highest quality care,” said Dr. Jeff Thramann, CEO of Auddia and founder of Influence Healthcare. “Only the physician has the knowledge, relationship with the patient, and clinical authority to make the many real-time decisions required to deliver the highest quality care at the lowest possible price. Influence Healthcare is aimed at leveraging AI to minimize administrative noise so that physicians are empowered to deliver the highest value care.”
The company’s model is built on the premise that physicians deliver value and should lead the system. By creating surgeon-led enterprises, Influence Healthcare ensures that surgeons retain governance authority and that episode-based economics flow to clinicians. Facilities participate through aligned partnerships rather than ownership. Post-merger, Influence Healthcare will leverage shared AI services from McCarthy Finney, the combined entity, to deploy agentic-AI workflows that eliminate administrative layers that have historically required multiple full-time staff per surgeon.
“AI should not replace physicians, it should replace the administrative friction that prevents physicians from practicing at the top of their license,” Dr. Thramann said. “Our platform gives surgeons the environment they need to deliver a more predictable, coordinated, efficient, and compassionate episode of care.”
Influence Healthcare’s initial focus is on spine and total joint surgery, with plans to expand to additional specialties and markets. The company’s model is designed to deliver lower total cost of care, improved outcomes through surgeon-led pathway design, reduced administrative overhead, predictable economics for payers and employers, and restored autonomy for surgeons.
The announcement comes as Auddia intends to file its S-4 later this week, the next step in the merger process that will combine Auddia with Thramann Holdings, which fully owns LT350, Influence Healthcare, and Voyex. Upon completion, Auddia will change its name to McCarthy Finney and trade under the ticker MCFN. For more information about Influence Healthcare, visit www.influencehealthcare.com.
About Auddia Inc.: Auddia, through its proprietary AI platform for audio, is reinventing how consumers engage with AM/FM radio, podcasts, and other audio content. Its flagship audio superapp, faidr, delivers ad-free listening, content skipping, and integrated artist discovery. For more information, visit www.auddia.com.
